Multifaceted Approach to Reduce Use of Meperidine in an Acute Care Setting

Latta K.S. , Ginsberg B. , Barkin R.L. Meperidine: a critical review. Am J Ther. 2002; 9: 53–68.

Gordon D.B. , Jones H.D. , Goshman L.M. , Foley D.K. , Bland S.E. A quality improvement approach to reducing use of meperidine. Jt Comm J Qual Improv. 2000; 26: 686–699.

Golembiewski J. Safety concerns with meperidine. J PeriAnesth Nurs. 2002; 17: 123–125.

Fulton C.W. Limiting meperidine use in pain management. Hosp Pharm. 2001; 36: 1214–1218.

Seifert C.F. , Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy. 2004; 24: 776–783.

Lee F. , Cundiff D. Meperidine vs morphine in pancreatitis and cholecystitis. Arch Intern Med. 1998; 158: 2399.

Boothby L.A. , Wang L. , MayHew S. , Chestnutt L. Academic detailing of meperidine at a teaching hospital. Hosp Pharm. 2003; 38: 30–35.

Beckwith M.C. , Fox E.R. , Chandramouli J. Removing meperidine from the health-system formulary—frequently asked questions. J Pain Palliat Care Pharmacother. 2002; 16: 45–59.

Vermeulen L.C. , Bollinger K.A. , Antonopoulos J. , Meek P.D. , Goshman L.M. , Ploetz P.A. Multifaceted approach to medication use policy development: the restriction of meperidine. Pharm Pract Manag Q. 1997; 16: 66–75.

Stevenson J.G. , Pearlman M. , Green C.R. . Altering meperidine prescribing patterns in a university teaching hospital. Jt Comm J Qual Saf. 2004; 30: 277–281,233.

Gutstein H.B. , Akil H. In: Brunton L.L. , Lazo J.S. , Parker K.L. eds. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw Hill; 2006; 547–590.

Fick D.M. , Cooper J.W. , Wade W.E. , Waller J.L. , Maclean J.R. , Beers M.H. Updating the Beer's criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003; 163: 2716–2724.

Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997; 157: 1531–1536.

Sporer K.A. The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Saf. 1995; 13: 94–104.

Mills K.C. Serotonin syndrome. Am Fam Physician. 1995; 52: 1475–1482.

Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 4th ed. Skokie, IL: The American Pain Society; 1999.

Thompson D. Narcotic analgesic effects on the sphincter of oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001; 96: 1266–1272.

Kornitzer B.S. , Manace L.C. , Fischberg D.J. , Leipzig R.M. Prevalence of meperidine use in older surgical patients. Arch Surg. 2006; 141: 76–81.

O'Connor A.B. , Lang V.J. , Quill T.E. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med. 2005; 118: 885–889.

Cutler D.M. , Feldman N.E. , Horwitz J.R. U.S. adoption of computerized physician order entry systems. Health Aff (Millwood). 2005; 24: 1654–1663.

Ash J.S. , Gorman P.N. , Seshadri V. , Hersh W.R. Computerized physician order entry in U.S. hospitals: results of a 2002 survey. J Am Med Inform Assoc. 2004;11: 95–99.